Latest papers

[An adult with chronic active Epstein-Barr virus infection associated with repeated liver dysfunction].

Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders in elderly white patients.

Post-transplant lymphoproliferative disorder presenting as multiple myeloma.

Diffuse large B-cell lymphoma in the spinal epidural space: A study of the Osaka Lymphoma Study Group

NK-cell lymphoma with nodal presentation and expression of cutaneous lymphocyte-associated antigen.

Primary cutaneous large B-cell lymphoma shows activation of nuclear factor kappa B and low incidence of Epstein-Barr virus.

Haemophagocytic syndrome and Hodgkin's disease variant of Richter's syndrome after fludarabine for CLL.

Genome-wide association studies: a primer.

Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation.

Lymphomatoid granulomatosis developing from chronic active Epstein-Barr virus infection in a patient with myelodysplastic syndrome.

Treatment advances in posttransplant lymphoproliferative disease.

EBV limbic encephalitis after allogenic hematopoietic stem cell transplantation.

Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma.

Photodynamic therapy-mediated modulation of inflammatory cytokine production by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.

Primary cutaneous giant cell plasmacytoma in an organ transplant recipient: a rare presentation of a posttransplant lymphoproliferative disorder.

Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.

Review: Epstein-Barr virus-associated smooth muscle tumors.

Lymphoepithelial-like carcinoma of the oropharynx: a morphologic variant of HPV-related head and neck carcinoma.

An Epstein-Barr virus-associated smooth muscle tumor successfully treated with surgical resection: a case report and literature review.

Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006.